14-24233585-A-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001002002.3(GMPR2):​c.194A>G​(p.Lys65Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,128 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)

Consequence

GMPR2
NM_001002002.3 missense

Scores

18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.584

Publications

3 publications found
Variant links:
Genes affected
GMPR2 (HGNC:4377): (guanosine monophosphate reductase 2) This gene encodes an enzyme that catalyzes the irreversible and NADPH-dependent reductive deamination of guanosine monophosphate (GMP) to inosine monophosphate (IMP). The protein also functions in the re-utilization of free intracellular bases and purine nucleosides. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.14138505).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GMPR2NM_001002002.3 linkc.194A>G p.Lys65Arg missense_variant Exon 3 of 10 ENST00000399440.7 NP_001002002.1 Q9P2T1-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GMPR2ENST00000399440.7 linkc.194A>G p.Lys65Arg missense_variant Exon 3 of 10 1 NM_001002002.3 ENSP00000382369.2 Q9P2T1-1

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152128
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
Cov.:
31
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152128
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74276
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41416
American (AMR)
AF:
0.00
AC:
0
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68032
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.625
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 06, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.248A>G (p.K83R) alteration is located in exon 2 (coding exon 2) of the GMPR2 gene. This alteration results from a A to G substitution at nucleotide position 248, causing the lysine (K) at amino acid position 83 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
17
DANN
Benign
0.89
DEOGEN2
Benign
0.40
.;T;T;T;T;.;T;T;T;T;.;.;.;.
Eigen
Benign
-0.85
Eigen_PC
Benign
-0.69
FATHMM_MKL
Benign
0.25
N
M_CAP
Benign
0.0094
T
MetaRNN
Benign
0.14
T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
0.095
.;N;N;.;.;.;.;.;.;N;.;.;.;N
PhyloP100
0.58
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.97
.;N;N;N;N;N;N;N;N;N;N;N;N;N
REVEL
Benign
0.14
Sift
Benign
0.49
.;T;T;T;T;T;T;T;T;T;T;T;T;T
Sift4G
Benign
0.47
T;T;T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.0010, 0.0020
.;B;B;.;.;.;.;.;.;B;B;.;.;.
Vest4
0.16
MutPred
0.50
Loss of ubiquitination at K65 (P = 0.0244);Loss of ubiquitination at K65 (P = 0.0244);Loss of ubiquitination at K65 (P = 0.0244);Loss of ubiquitination at K65 (P = 0.0244);Loss of ubiquitination at K65 (P = 0.0244);Loss of ubiquitination at K65 (P = 0.0244);Loss of ubiquitination at K65 (P = 0.0244);Loss of ubiquitination at K65 (P = 0.0244);.;Loss of ubiquitination at K65 (P = 0.0244);.;.;.;Loss of ubiquitination at K65 (P = 0.0244);
MVP
0.58
MPC
0.14
ClinPred
0.14
T
GERP RS
2.1
Varity_R
0.16
gMVP
0.60
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1226919098; hg19: chr14-24702791; COSMIC: COSV99164569; COSMIC: COSV99164569; API